How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Protein Sequencing Service Market
- By Sequencing Technology: Mass Spectrometry-Based Sequencing, Edman Degradation, Tandem Mass Spectrometry (MS/MS), De Novo Sequencing, Peptide Mapping
- By Service Mode: Contract Research Services, In-House Sequencing Services, Outsourced Sequencing Services, Custom Protein Sequencing
- By Application: Biopharmaceutical Development, Proteomics Research, Quality Control and Assurance, Biomarker Discovery, Structural Biology
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Diagnostic Laboratories, Food and Beverage Industry
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Mass Spectrometry-Based Sequencing leads By Sequencing Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Protein Sequencing Service Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Sequencing Technology 5
Service Mode 4
Application 5
End User 5
Companies profiled
Thermo Fisher Scientific
Agilent Technologies
Bruker Corporation
SCIEX (a Danaher company)
Bio-Rad Laboratories
Waters Corporation
Shimadzu Corporation
PerkinElmer
Eurofins Scientific
GenScript Biotech Corporation
Novogene
Creative Proteomics
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Agilent Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bruker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →SCIEX (a Danaher company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Waters Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Shimadzu Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →PerkinElmer
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Eurofins Scientific
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →GenScript Biotech Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Novogene
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Creative Proteomics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Proteome Sciences
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →BGI Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Fujifilm Wako Chemicals
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,164M by 2033 · 10.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Mass Spectrometry-Based Sequencing51.1
- Edman Degradation12.4
- Tandem Mass Spectrometry (MS/MS)9.9
- De Novo Sequencing17.2
- Peptide Mapping9.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$783.3M → $1,597M · 9.3%
Europe$545.9M → $1,305M · 11.5%
Asia Pacific$498.4M → $1,189M · 11.5%
Latin America$308.6M → $678.2M · 10.3%
Middle East and Africa$237.4M → $507.9M · 10.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.172026
10.172027
10.182028
10.192029
10.202030
10.222031
10.232032
10.242033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific20.9
- Agilent Technologies15.6
- Bruker Corporation8.1
- SCIEX (a Danaher company)10.1
- Bio-Rad Laboratories9.3
- Waters Corporation8.1
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Sequencing Technology26.9%
Service Mode13.3%
Application25.8%
End User33.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.3
- Europe24.7
- Asia Pacific22.5
- Latin America12.9
- Middle East and Africa9.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 91 | 92 | 78 | 90 | 94 | 97 | 90 |
| Agilent Technologies | 70 | 93 | 74 | 87 | 73 | 73 | 78 |
| Bruker Corporation | 88 | 64 | 64 | 73 | 77 | 78 | 74 |
| SCIEX (a Danaher company) | 76 | 81 | 73 | 61 | 80 | 65 | 73 |
| Bio-Rad Laboratories | 58 | 74 | 67 | 51 | 66 | 76 | 65 |
| Waters Corporation | 56 | 52 | 48 | 58 | 56 | 57 | 55 |
| Shimadzu Corporation | 59 | 53 | 43 | 65 | 56 | 46 | 54 |
| PerkinElmer | 41 | 41 | 41 | 59 | 48 | 46 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Agilent Technologies
- Bruker Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Agilent Technologies | ✓ | ✓ | ◐ | ✓ | ◐ | ✓ |
| Bruker Corporation | ✓ | ◐ | ✓ | ◐ | ◐ | ◐ |
| SCIEX (a Danaher company) | ◐ | ◐ | ◐ | ◐ | ✓ | − |
| Bio-Rad Laboratories | − | ◐ | ◐ | − | − | ✓ |
| Waters Corporation | ◐ | ◐ | ◐ | ◐ | − | − |
| Shimadzu Corporation | ◐ | − | − | ◐ | − | − |
| PerkinElmer | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific90
2Agilent Technologies78
3Bruker Corporation74
4SCIEX (a Danaher company)73
5Bio-Rad Laboratories65
6Waters Corporation55
7Shimadzu Corporation54
8PerkinElmer46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificAgilent Technologies
Challenger2
Strong scale, closing on the leaders.
Bruker CorporationSCIEX (a Danaher company)
Contender1
Focused players with pockets of strength.
Bio-Rad Laboratories
Niche3
Specialists in a single segment or region.
Waters CorporationShimadzu CorporationPerkinElmer
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Sequencing Technology in North America, then scale across Protein Sequencing Service Market — a $520M beachhead inside a $7.44B market.
Beachhead (SOM)$520Mobtainable near-term
Serviceable (SAM)$3.10Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Mass Spectrometry-Based Sequencing
Best fit — highest urgency & budget in Sequencing Technology.
Economic buyer80 fit
Edman Degradation
Strong fit — clear ROI and a fast path to value.
End user65 fit
Tandem Mass Spectrometry (MS/MS)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Sequencing Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Service Mode & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve18%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Sequencing Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Protein Sequencing Service Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified22%
Evaluation15%
Closed-won7%
$9.2KCAC
$49KLTV
5.3:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Protein Sequencing Service Market is a durable-growth opportunity — $9.26B by 2033, compounding at 7.8%.
TAM · 2025$5.06Btoday
TAM · 2033$9.26Bforecast
CAGR7.8%2027–2033
Cumulative$62.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.26BTotal addressable market
SAM$3.43BServiceable available market
SOM$696MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.8% CAGR
Demand compounds through 2033, outpacing GDP across Sequencing Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Sequencing Technology moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.26BLarge & growingTAM by 2033 at 7.8% CAGR
$3.43BServiceable nowreachable with today’s model
$696MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.22BBear5.1% CAGR
$9.26BBase7.8% CAGR
$11.9BBull10.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Service Mode optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Protein Sequencing Service Market — a $1.20B market by 2033. Plan: grow share from 7.1% to 14.5%.
Market size · 2033$1.20Btotal addressable
Market CAGR10.5%2027–2033
Target share14.5%from 7.1% today
Revenue ambition$175Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.1% | 14.5% | Ahead |
| Revenue | $93M | $175M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 33.3% | 39.9% | On track |
| Customer retention | 87.1% | 95.2% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Sequencing Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Service Mode capability
A defensible second engine — invest in Service Mode to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Sequencing Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Service Mode
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $22M capacity & capability investment
- Greenlight bolt-on M&A in Service Mode
- Authorise North America expansion plan
- Fund R&D program for Sequencing Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Protein Sequencing Service Market conversation — a $2.29B market you can size, segment and defend in minutes.
Market size · 2033$2.29Btotal opportunity
Growth9.5%CAGR to 2033
Addressable buyers985+accounts in scope
Typical ROI6.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Sequencing Technology
Goal Grow share in Sequencing Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.9×return on cost, year one
< 2 mopayback period
$81K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificAgilent TechnologiesBruker CorporationSCIEX (a Danaher company)Bio-Rad LaboratoriesWaters CorporationShimadzu CorporationPerkinElmer+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Protein Sequencing Service Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Protein Sequencing Service Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Protein Purification Workstations Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportProtein Purification Reagent Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportProtein Purification Medium Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportProtein Purification Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportProtein Purification Magnetic Beads Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportProtein Purification Kits Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportProtein Purification - Isolation Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportProtein Purification Equipment Market
Market size, share, segmentation and regional forecast.
$864M market · 2025 base year
View reportProtein Purification Detergent Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportProtein Purification Column Market
Market size, share, segmentation and regional forecast.
$748M market · 2025 base year
View reportProtein Purification Chromatography Column Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportProtein Purification and Isolation Hardware Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.